CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
57 hedge funds and large institutions have $23.4M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-10
Holders Change %
-14.93%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
19
Closed
16
Calls
$169K
Puts
$61K
Net Calls
+$108K
Net Calls Change
+$121K
Top Buyers
| 1 |
Millennium Management
New York
|
+$593K |
| 2 |
Goldman Sachs
New York
|
+$326K |
| 3 |
Renaissance Technologies
New York
|
+$270K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$197K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$179K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.11M |
| 2 |
State Street
Boston,
Massachusetts
|
-$834K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$385K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$212K |
| 5 |
Bank of New York Mellon
New York
|
-$159K |
